Actual Medicinal Product (AMP) Fingolimod 500microgram capsules (Amarox Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Store in an airtight container and protect from moisture.
- Provenance
-
This compatibility recommendation is derived from Gilenya 0.5mg capsules (Novartis Pharmaceuticals UK Ltd).
- Generic
- Fingolimod
- Formulation
- Fingolimod 500microgram capsules
-
Fingolimod
-
Fingolimod 500microgram capsules
-
Fingolimod 500microgram capsules (Amarox Ltd)
-
-
Fingolimod 250microgram capsules